Should iShares Core S&P Small-Cap ETF (IJR) Be on Your Investing Radar?
Style Box ETF report for IJR
Zacks
More News
What's Next for Small Caps After a Stellar First Half?
We examine the investment case for small-cap stocks.
Zacks
CNMD Stock Surges As Much As 10% After-Hours On Reports Of Private Equity Takeover Interest
The medical technology company is working with advisers to evaluate strategic options, Bloomberg Law reported, citing people familiar with the matter.
Stocktwits
This Analyst Sees 34% Upside For SRPT Stock — Here's Why They Expect A Sustained Rally Next
Analysts at Wolfe Research upgraded Sarepta to ‘Outperform’ from ‘Peer Perform,’ with a price target of $27.
Stocktwits
ALHC Stock Clocks Worst Day In Over 2 Years On Whistleblower Financial Manipulation Allegation
Hakan Kardes claims in the suit filed in the U.S. District Court for the Central District of California that the company forced him to resign after he reported alleged accounting fraud to other executives.
Stocktwits
This AI Infrastructure Stock Has Soared Over 220% This Year — Why Wall Street Sees Another 36% Upside Potential
Analysts at Citizens raised their price target for Penguin Solutions to $85 from $65 while keeping an ‘Outperform’ rating.
Stocktwits
TGTX Stock Rises On Wall Street Price Target Hike, New Schizophrenia Trial Launch
Bank of America analyst Alec Stranahan raised his price target on TG Therapeutics to $20 from $17 but kept an ‘Underperform’ rating on the shares.
Stocktwits
Can Small-Cap Stocks Continue to Outperform?
Small-cap stocks surged in 1H. We highlight three ETFs.
Zacks
TMDX Stock Rallies As Analyst Sees 77% Upside — Here’s Why
TD Cowen maintained its ‘Buy’ rating on TransMedics with a $120 price target.
Stocktwits
SRPT Stock Climbs After Sarepta Seeks Permanent FDA Nod For Two Duchenne Therapies
Sarepta is seeking full approval for Amondys 45 and Vyondys 53 in Duchenne muscular dystrophy.